UnitedHealth Group reported strong first-quarter earnings with revenues up 9% and adjusted EPS growing 23%, and they've raised their earnings expectations for 2019. Management expressed confidence in future growth, highlighting positive developments in their Optum and UnitedHealthcare divisions, as well as successful cost management. Given the robust financial performance and optimistic guidance, the stock is likely to see a positive impact in the short term.

[1]